tyrosine has been researched along with tautomycin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Charlet-Berguerand, N; Elliott, DJ; Gattoni, R; Hagerman, PJ; Hukema, RK; Liu, Y; Rau, F; Richard, S; Schneider, A; Sellier, C; Tassone, F; Willemsen, R | 1 |
Chan, RJ; Gunawan, AM; Huang, SX; Liu, S; Luo, Y; Shen, B; Shen, W; Wang, L; Wu, L; Yang, Z; Yu, X; Yu, Z; Zhang, ZY | 1 |
2 other study(ies) available for tyrosine and tautomycin
Article | Year |
---|---|
Sam68 sequestration and partial loss of function are associated with splicing alterations in FXTAS patients.
Topics: Adaptor Proteins, Signal Transducing; Alternative Splicing; Animals; Ataxia; Cell Nucleus; Chlorocebus aethiops; COS Cells; DNA-Binding Proteins; Enzyme Inhibitors; Fragile X Syndrome; Heterogeneous-Nuclear Ribonucleoproteins; Humans; Mice; Phosphorylation; Pyrans; Repetitive Sequences, Nucleic Acid; RNA-Binding Proteins; RNA, Messenger; Spiro Compounds; Tyrosine | 2010 |
SHP2 is a target of the immunosuppressant tautomycetin.
Topics: Amino Acid Sequence; Cell Differentiation; Cell Proliferation; Enzyme Activation; Enzyme Inhibitors; Furans; Hematopoietic Stem Cells; Humans; Immunosuppressive Agents; Jurkat Cells; Lipids; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Models, Molecular; Molecular Sequence Data; Monocytes; Phosphorylation; Protein Conformation; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Pyrans; Signal Transduction; Spiro Compounds; Substrate Specificity; Tyrosine | 2011 |